← Leaderboards
Shahriar Mobashery
University Of Notre Dame
$28,662,632
Attributed
$32,830,281
Total exposure
14
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$32,830,281 · 14
By mechanism
R01$28,211,373 · 8
R35$2,336,495 · 2
T32$1,427,413 · 1
S10$850,000 · 2
R13$5,000 · 1
Top collaborators
- Mayland F Chang15 shared
Most similar at University Of Notre Dame
Same institution · by research overlap
- Mayland F Chang$8,633,703
- Cindy S Bergeman$9,447,550
- Marvin J Miller$13,460,176
Others in their field
Top investigators on “Antibiotics”
- Laurence H Baker · University Of Michigan At Ann Arbor$52,071,546
- Clarence Buddy Creech · Vanderbilt University Medical Center$43,812,829
- Taha E Taha · Johns Hopkins University$37,363,329
- Urs Ochsner · Crestone, Inc.$36,950,837
- Deborah T Hung · Massachusetts General Hospital$36,871,538
- Ryan Cirz · Revagenix, Inc.$35,410,554
Research focus
AntibioticsResistanceComplexMonobactamsApplications GrantsLeadProteinsEnzymesBacteriaCell WallResistance MechanismSciencePenicillin-Binding ProteinsEventBeta-LactamsReactionOrganismAntibiotic ResistanceStructurePseudomonas AeruginosaPropertyBaseIn VitroCytoplasm
Grant awards (83)
Beta-Lactam Resistance Mechanisms of Staphylococcus aureus$630,355
R01 · FY2025 · AI · contact PI
Targeting Gram-Negative Bacteria for Antibacterial Strategies$414,725
R35 · FY2025 · GM · contact PI
Beckman Optima A/I Analytical Ultracentrifuge (AUC)$350,000
S10 · FY2025 · OD · contact PI
Beta-Lactam Resistance Mechanisms of Staphylococcus aureus$630,355
R01 · FY2024 · AI · contact PI
Bulgecin Template for Potentiation of beta-Lactam Antibiotics$629,042
R01 · FY2024 · AI · contact PI
Beta-Lactam Resistance Mechanisms of Staphylococcus aureus$663,960
R01 · FY2023 · AI · contact PI
Bulgecin Template for Potentiation of beta-Lactam Antibiotics$629,042
R01 · FY2023 · AI · contact PI
Cell-Wall Recycling and Nexus to Antibiotic Resistance$386,250
R35 · FY2023 · GM · contact PI
Bulgecin Template for Potentiation of beta-Lactam Antibiotics$629,042
R01 · FY2022 · AI · contact PI
Inducible Antibiotic Resistance in Methicillin-Resistant Staphylococcus aureus$518,582
R01 · FY2022 · AI · contact PI
Cell-Wall Recycling and Nexus to Antibiotic Resistance$386,250
R35 · FY2022 · GM · contact PI
Bulgecin Template for Potentiation of beta-Lactam Antibiotics$629,042
R01 · FY2021 · AI · contact PI
Inducible Antibiotic Resistance in Methicillin-Resistant Staphylococcus aureus$518,582
R01 · FY2021 · AI · contact PI
Cell-Wall Recycling and Nexus to Antibiotic Resistance$386,250
R35 · FY2021 · GM · contact PI
Chemistry-Biochemistry-Biology Interface (CBBI) Program at Notre Dame$289,762
T32 · FY2021 · GM
Inducible Antibiotic Resistance in Methicillin-Resistant Staphylococcus aureus$518,582
R01 · FY2020 · AI · contact PI
Bulgecin Template for Potentiation of beta-Lactam Antibiotics$502,025
R01 · FY2020 · AI · contact PI
Cell-Wall Recycling and Nexus to Antibiotic Resistance$386,250
R35 · FY2020 · GM · contact PI
Chemistry-Biochemistry-Biology Interface (CBBI) Program at Notre Dame$289,234
T32 · FY2020 · GM
Inducible Antibiotic Resistance in Methicillin-Resistant Staphylococcus aureus$518,582
R01 · FY2019 · AI · contact PI
Cell-Wall Recycling and Nexus to Antibiotic Resistance$376,770
R35 · FY2019 · GM · contact PI
Chemistry-Biochemistry-Biology Interface (CBBI) Program at Notre Dame$285,968
T32 · FY2019 · GM
Inducible Antibiotic Resistance in Methicillin-Resistant Staphylococcus aureus$518,582
R01 · FY2018 · AI · contact PI
Cell-Wall Recycling and Antibiotic Resistance$320,588
R01 · FY2018 · GM · contact PI
Chemistry-Biochemistry-Biology Interface (CBBI) Program at Notre Dame$282,780
T32 · FY2018 · GM
Inducible Antibiotic Resistance in Methicillin-Resistant Staphylococcus Aureus$425,919
R01 · FY2017 · AI · contact PI
Cell-Wall Recycling and Antibiotic Resistance$320,588
R01 · FY2017 · GM · contact PI
Chemistry-Biochemistry-Biology Interface (CBBI) Program at Notre Dame$279,669
T32 · FY2017 · GM
Inducible Antibiotic Resistance in Methicillin-Resistant Staphylococcus Aureus$425,919
R01 · FY2016 · AI · contact PI
Cell-Wall Recycling and Antibiotic Resistance$315,400
R01 · FY2016 · GM · contact PI
Inducible Antibiotic Resistance in Methicillin-Resistant Staphylococcus Aureus$471,519
R01 · FY2015 · AI · contact PI
Maturation of Bacterial Cell Wall$375,000
R01 · FY2015 · AI · contact PI
Cell-Wall Recycling and Antibiotic Resistance$315,400
R01 · FY2015 · GM · contact PI
Novel oxadiazols for the treatment of drug-resistant gram-positive bacteria$990,528
R01 · FY2014 · AI
Inducible Antibiotic Resistance in Methicillin-Resistant Staphylococcus Aureus$471,519
R01 · FY2014 · AI · contact PI
Maturation of Bacterial Cell Wall$375,000
R01 · FY2014 · AI · contact PI
Cell-Wall Recycling and Antibiotic Resistance$315,400
R01 · FY2014 · GM · contact PI
Novel oxadiazols for the treatment of drug-resistant gram-positive bacteria$944,017
R01 · FY2013 · AI
Inducible Antibiotic Resistance in Methicillin-Resistant Staphylococcus Aureus$400,363
R01 · FY2013 · AI · contact PI
Maturation of Bacterial Cell Wall$352,500
R01 · FY2013 · AI · contact PI
Cell-Wall Recycling and Antibiotic Resistance$315,400
R01 · FY2013 · GM · contact PI
Novel oxadiazols for the treatment of drug-resistant gram-positive bacteria$1,016,761
R01 · FY2012 · AI
Maturation of Bacterial Cell Wall$375,000
R01 · FY2012 · AI · contact PI
Bacterial Cell Wall and its Turnover$301,381
R01 · FY2012 · GM · contact PI
2012 New Antibacterial Drug Discovery and Development Gordon Research Conference$5,000
R13 · FY2012 · AI · contact PI
Novel oxadiazols for the treatment of drug-resistant gram-positive bacteria$1,019,120
R01 · FY2011 · AI
Maturation of Bacterial Cell Wall$375,000
R01 · FY2011 · AI · contact PI
Intervention of Disease by Selective Gelatinase Inhibitors$364,376
R01 · FY2011 · CA · contact PI
Bacterial Cell Wall and its Turnover$301,381
R01 · FY2011 · GM · contact PI
Novel oxadiazols for the treatment of drug-resistant gram-positive bacteria$1,069,649
R01 · FY2010 · AI
Intervention of Disease by Selective Gelatinase Inhibitors$380,625
R01 · FY2010 · CA · contact PI
Resistance to beta-Lactam Antibiotics$343,734
R01 · FY2010 · AI · contact PI
Bacterial Cell Wall and its Turnover$304,425
R01 · FY2010 · GM · contact PI
Intervention of Disease by Selective Gelatinase Inhibitors$378,191
R01 · FY2009 · CA · contact PI
Resistance to beta-Lactam Antibiotics$347,205
R01 · FY2009 · AI · contact PI
Bacterial Cell Wall and its Turnover$307,500
R01 · FY2009 · GM · contact PI
Intervention of Disease by Selective Gelatinase Inhibitors$372,202
R01 · FY2008 · CA · contact PI
Resistance to beta-Lactam Antibiotics$347,205
R01 · FY2008 · AI · contact PI
Penicillin-Binding Proteins, Mechanism and Inhibition$263,121
R01 · FY2008 · GM · contact PI
Intervention of Disease by Selective Gelatinase Inhibitors$372,417
R01 · FY2007 · CA · contact PI
Resistance to beta-Lactam Antibiotics$353,930
R01 · FY2007 · AI · contact PI
RIBOSOMAL FUNCTION & ANTIBIOTIC DESIGN$267,689
R01 · FY2007 · AI · contact PI
Penicillin-Binding Proteins, Mechanism and Inhibition$263,121
R01 · FY2007 · GM · contact PI
Resistance to beta-Lactam Antibiotics$377,000
R01 · FY2006 · AI · contact PI
RIBOSOMAL FUNCTION & ANTIBIOTIC DESIGN$275,684
R01 · FY2006 · AI · contact PI
Penicillin-Binding Proteins, Mechanism and Inhibition$270,979
R01 · FY2006 · GM · contact PI
RIBOSOMAL FUNCTION &ANTIBIOTIC DESIGN$282,318
R01 · FY2005 · AI
Penicillin-Binding Proteins, Mechanism and Inhibition$277,500
R01 · FY2005 · GM
RESISTANCE TO BETA-LACTAM ANTIBIOTICS$330,288
R01 · FY2004 · AI
RIBOSOMAL FUNCTION &ANTIBIOTIC DESIGN$282,318
R01 · FY2004 · AI
Penicillin-Binding Proteins, Mechanism and Inhibition$220,894
R01 · FY2004 · GM
RESISTANCE TO BETA-LACTAM ANTIBIOTICS$288,833
R01 · FY2003 · AI
Penicillin-Binding Proteins, Mechanism and Inhibition$158,895
R01 · FY2003 · GM
RIBOSOMAL FUNCTION &ANTIBIOTIC DESIGN$153,284
R01 · FY2003 · AI
Penicillin-Binding Proteins, Mechanism and Inhibition$57,889
R01 · FY2003 · GM
RESISTANCE TO BETA-LACTAM ANTIBIOTICS$33,373
R01 · FY2003 · AI
RIBOSOMAL FUNCTION &ANTIBIOTIC DESIGN$1
R01 · FY2003 · AI
Acquisition of a 600 MHz NMR Spectrometer - Wayne State$500,000
S10 · FY2002 · RR
RESISTANCE TO BETA-LACTAM ANTIBIOTICS$331,373
R01 · FY2002 · AI
Penicillin-Binding Proteins, Mechanism and Inhibition$219,889
R01 · FY2002 · GM
RESISTANCE TO BETA-LACTAM ANTIBIOTICS$331,373
R01 · FY2001 · AI
Penicillin-Binding Proteins, Mechanism and Inhibition$242,731
R01 · FY2001 · GM
RESISTANCE TO BETA-LACTAM ANTIBIOTICS$281,885
R01 · FY2000 · AI